# Safety and Tolerability of Single and Multiple Doses of Neumifil

> **NCT05093530** · PHASE1 · COMPLETED · sponsor: **Pneumagen Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Viral Respiratory Tract Infection

## Interventions

- **DRUG:** Neumifil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05093530
- **Lead sponsor:** Pneumagen Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-12
- **Primary completion:** 2022-04-05
- **Final completion:** 2022-04-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05093530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05093530, "Safety and Tolerability of Single and Multiple Doses of Neumifil". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05093530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*